Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture...

Presented by

Dr John Metcalfe, Senior Pharmaceutical Quality Assessor at FDA and Dr. Doug Botkin at Charles River Laboratories

About this talk

Full title: Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture: Updates from a CDER Microbiologist's Perspective During this webinar, Dr. Metcalfe will: Provide a short background regarding FDA concerns pertaining to Burkholderia cepacia Complex (BCC) and the manufacture of non-sterile drug products Provide reference to pertinent areas of the 2021 FDA Draft Guidance for Industry-Microbiological Quality Considerations in Non-sterile Drug Product Manufacturing Present recent events in the US pertaining to BCC Explore recent FDA Warning Letters to address common industry questions regarding BCC and the manufacture of non-sterile drugs
Related topics:

More from this channel

Upcoming talks (40)
On-demand talks (352)
Subscribers (36498)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.